Osaka, Japan

Nobuyuki Sigetoh


Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1995-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Nobuyuki Sigetoh: Innovator in Monoclonal Antibody Development

Introduction

Nobuyuki Sigetoh is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 3 patents, his work focuses on innovative methods for detecting cocaine and its derivatives.

Latest Patents

Sigetoh's latest patents include a cocaine derivative, a protein conjugate thereof, and a monoclonal antibody producing cell line. His method for preparing the cell line and monoclonal antibody involves using a cocaine derivative that has a methoxy carbonyl group and a benzoyl group. This conjugate is particularly useful for the detection of cocaine or its derivatives. Additionally, he describes a method for producing a monoclonal antibody producing cell line using the cocaine-protein conjugate as an immunogen.

Career Highlights

Nobuyuki Sigetoh is associated with Matsushita Electric Industrial Co., Ltd., where he has been able to apply his innovative ideas in a corporate setting. His work has not only advanced scientific understanding but also has practical applications in drug detection.

Collaborations

Sigetoh has collaborated with notable colleagues such as Jinsei Miyazaki and Keiko Yugawa. These partnerships have likely contributed to the success and development of his innovative projects.

Conclusion

Nobuyuki Sigetoh's contributions to the field of biotechnology, particularly in monoclonal antibody development, highlight his role as an influential inventor. His innovative methods for detecting cocaine derivatives demonstrate the practical applications of his research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…